190 related articles for article (PubMed ID: 37513221)
1. The Synthesis and Biological Evaluation of 2-(1
Mendogralo EY; Nesterova LY; Nasibullina ER; Shcherbakov RO; Tkachenko AG; Sidorov RY; Sukonnikov MA; Skvortsov DA; Uchuskin MG
Molecules; 2023 Jul; 28(14):. PubMed ID: 37513221
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, Antimicrobial and Antibiofilm Activities, and Molecular Docking Investigations of 2-(1
Mendogralo EY; Nesterova LY; Nasibullina ER; Shcherbakov RO; Myasnikov DA; Tkachenko AG; Sidorov RY; Uchuskin MG
Molecules; 2023 Oct; 28(20):. PubMed ID: 37894573
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and evaluation of new quinazolin-4(3H)-one derivatives as potent antibacterial agents against multidrug resistant Staphylococcus aureus and Mycobacterium tuberculosis.
Gatadi S; Gour J; Shukla M; Kaul G; Dasgupta A; Madhavi YV; Chopra S; Nanduri S
Eur J Med Chem; 2019 Aug; 175():287-308. PubMed ID: 31096152
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, Molecular Docking Studies and Antibacterial Activities of Novel Monocationic Indole-benzimidazole Derivatives.
Ates-Alagoz Z; Kisla MM; Goker H; Yildiz S
Med Chem; 2021; 17(7):699-706. PubMed ID: 32310051
[TBL] [Abstract][Full Text] [Related]
5. Antibacterial Activity of Quinoline-Based Derivatives against Methicillin-Resistant Staphylococcus aureus and Pseudomonas aeruginosa: Design, Synthesis, DFT and Molecular Dynamic Simulations.
Sabt A; Abdelraof M; Hamissa MF; Noamaan MA
Chem Biodivers; 2023 Nov; 20(11):e202300804. PubMed ID: 37933986
[TBL] [Abstract][Full Text] [Related]
6. Design, Synthesis and Biological Evaluation of Novel Pleuromutilin Derivatives Containing 6-Chloro-1-R-1
Wang J; Hu YH; Zhou KX; Wang W; Li F; Li K; Zhang GY; Tang YZ
Molecules; 2023 May; 28(9):. PubMed ID: 37175382
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and biological evaluation of novel pleuromutilin derivatives possessing 4-aminothiophenol linker as promising antibacterial agents.
Chai F; Wang J; Zhou KX; Wang SK; Liu YH; Jin Z; Tang YZ
Bioorg Chem; 2022 Sep; 126():105859. PubMed ID: 35605553
[TBL] [Abstract][Full Text] [Related]
8. Antibacterial activity evaluation of pleuromutilin derivatives with 4(3H)-quinazolinone scaffold against methicillin-resistant Staphylococcusaureus.
Deng Y; Zhang Y; Chen XH; Li CH
Eur J Med Chem; 2023 Jan; 246():114960. PubMed ID: 36462445
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, molecular docking study, and antibacterial evaluation of some new fluoroquinolone analogues bearing a quinazolinone moiety.
Norouzbahari M; Salarinejad S; Güran M; Şanlıtürk G; Emamgholipour Z; Bijanzadeh HR; Toolabi M; Foroumadi A
Daru; 2020 Dec; 28(2):661-672. PubMed ID: 33030668
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, and biological evaluation of novel pleuromutilin derivatives containing benzimidazoles as effective anti-MRSA agents.
Zhang QW; Ren J; Lu JX; Chen XY; He XJ; Wang Q; Zhou ZD; Jin Z; Zeng ZL; Tang YZ
Drug Dev Res; 2023 Nov; 84(7):1437-1452. PubMed ID: 37534779
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, biological screening and in silico studies of new N-phenyl-4-(1,3-diaryl-1H-pyrazol-4-yl)thiazol-2-amine derivatives as potential antifungal and antitubercular agents.
Nandurkar Y; Bhoye MR; Maliwal D; Pissurlenkar RRS; Chavan A; Katade S; Mhaske PC
Eur J Med Chem; 2023 Oct; 258():115548. PubMed ID: 37307623
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial activity of novel 5-benzylidene-3-(3-phenylallylideneamino)imidazolidine-2,4-dione derivatives causing clinical pathogens: Synthesis and molecular docking studies.
Ali D; Alarifi S; Chidambaram SK; Radhakrishnan SK; Akbar I
J Infect Public Health; 2020 Dec; 13(12):1951-1960. PubMed ID: 33289644
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and antibacterial evaluation of (E)-1-(1H-indol-3-yl) ethanone O-benzyl oxime derivatives against MRSA and VRSA strains.
Akunuri R; Veerareddy V; Kaul G; Akhir A; Unnissa T; Parupalli R; Madhavi YV; Chopra S; Nanduri S
Bioorg Chem; 2021 Nov; 116():105288. PubMed ID: 34454299
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of new quinazoline-benzimidazole hybrids as potent anti-microbial agents against multidrug resistant Staphylococcus aureus and Mycobacterium tuberculosis.
Malasala S; Ahmad MN; Akunuri R; Shukla M; Kaul G; Dasgupta A; Madhavi YV; Chopra S; Nanduri S
Eur J Med Chem; 2021 Feb; 212():112996. PubMed ID: 33190958
[TBL] [Abstract][Full Text] [Related]
15. Discovery of quinolinequinones with N-phenylpiperazine by conversion of hydroxyquinoline as a new class of antimicrobial agents targeting resistant pathogenic microorganisms.
Yıldız M; Bayrak N; Yıldırım H; Çakmak SM; Yılmaz FN; Mataracı-Kara E; Shilkar D; Jayaprakash V; TuYuN AF
Bioorg Chem; 2022 Nov; 128():106045. PubMed ID: 35921788
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, Biological Evaluation and Molecular Docking Studies of 5-Indolylmethylen-4-oxo-2-thioxothiazolidine Derivatives.
Horishny V; Geronikaki A; Kartsev V; Matiychuk V; Petrou A; Pogodin P; Poroikov V; Papadopoulou TA; Vizirianakis IS; Kostic M; Ivanov M; Sokovic M
Molecules; 2022 Feb; 27(3):. PubMed ID: 35164333
[TBL] [Abstract][Full Text] [Related]
17. Diaryltriazenes as antibacterial agents against methicillin resistant Staphylococcus aureus (MRSA) and Mycobacterium smegmatis.
Vajs J; Proud C; Brozovic A; Gazvoda M; Lloyd A; Roper DI; Osmak M; Košmrlj J; Dowson CG
Eur J Med Chem; 2017 Feb; 127():223-234. PubMed ID: 28063354
[TBL] [Abstract][Full Text] [Related]
18. Semisynthetic pleuromutilin antimicrobials with therapeutic potential against methicillin-resistant Staphylococcus aureus by targeting 50S ribosomal subunit.
Wang X; Wang R; Zhang ZS; Zhang GY; Jin Z; Shen R; Du D; Tang YZ
Eur J Med Chem; 2022 Jul; 237():114341. PubMed ID: 35430480
[TBL] [Abstract][Full Text] [Related]
19. Potential Fluorinated Anti-MRSA Thiazolidinone Derivatives with Antibacterial, Antitubercular Activity and Molecular Docking Studies.
Kumar V; Shetty P; H S A; Chandra K S; Ramu R; Patil SM; Baliga A; Rai VM; M SS; Udupi V; Poojary V; Poojary B
Chem Biodivers; 2022 Feb; 19(2):e202100532. PubMed ID: 34929067
[TBL] [Abstract][Full Text] [Related]
20. 1-(1H-indol-3-yl)ethanamine derivatives as potent Staphylococcus aureus NorA efflux pump inhibitors.
Hequet A; Burchak ON; Jeanty M; Guinchard X; Le Pihive E; Maigre L; Bouhours P; Schneider D; Maurin M; Paris JM; Denis JN; Jolivalt C
ChemMedChem; 2014 Jul; 9(7):1534-45. PubMed ID: 24677763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
